Photocure Signs Hexvix Distribution Deal With Clinigen

MT Newswires · 4d ago
03:19 AM EST, 11/18/2026 (MT Newswires) -- Photocure (PHO.OL) partnered with Clinigen for the global supply of its bladder cancer detection drug Hexvix in more than 40 markets where it is not yet available or approved, the bladder cancer-focused company said Wednesday. The drug will be marketed under a named patient program, allowing physicians to prescribe Hexvix in case they think a bladder cancer patient would benefit from blue light cystoscopy, subject to local laws.